Trevena

Trevena is a privately-held clinical-stage biopharmaceutical company headquartered in King of Prussia, Pennsylvania, dedicated to the discovery and development of GPCR-biased ligands. Trevena was founded in late 2007 with the aim of translating groundbreaking research on GPCR signaling into a new generation of drugs.